---
title: "Breast cancer main pathway"
slug: "breast-cancer-main-pathway"
date: "2023-10-05"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Clinical Pathway-of-breast cancer]]

# Breast cancer main pathway

## W/u

- CBC
- [[CEA]], CA15-3
- Liver function test
- Chest x-ray
- [[Mammography]]
- Ultrasonography of both breasts
- Pathology review
- Ultrasonography of liver ***
-

## Wide excision or Mastectomy
>
> ALND or [[SLNB]]

## N postive or negative âŠ• âŠ–

- [[Node negative-of-Breast cancer main pathway]]ðŸ˜Š
- [[Node positive-of-Breast cancer main pathway]] ðŸ˜©
- [[Radiation therapy indications for mastectomy patients]] see page 6
  - all patient receiving breast conserving therapy (after chemotherapy)
- Hormone therapy if HR(+)
  - qv [[adjuvant endocrine therapy for breast cancer]]

1. [[Tamoxifen]] as the drug of choice.  If intolerable side effect, consider aromatase inhibitor.
2. adjuvant  Herceptin for patients with HER2 over-expression, node(-), tumor size > 1 cm, after adjuvant chemotherapy.
3. [[CMF]] x8 : optional for old-aged or with other co-morbidities. [[TC]] x6: optional for patient to avoid cardiac toxicity and want to omit anthracycline..
